Search research articles
Contact Us
Filters
Showing results (831-840 of 898) with videos related to
Page
of 90
Sort By:
American Journal of Surgery
|
August 8, 2022
Patient characteristics and diagnostic tests associated with syncopal falls: A Southwestern surgical congress multicenter study
Janet S Lee, Abid D Khan, Christopher M Quinn, et al.
Blood
|
March 14, 2022
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML
H Moses Murdock, Haesook T Kim, Nathan Denlinger, et al.
Blood Advances
|
June 28, 2024
Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML
Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, et al.
Blood
|
August 18, 2023
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy
Peter G Miller, Adam S Sperling, Christina Mayerhofer, et al.
Blood Advances
|
July 21, 2019
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation
Max Jan, Matthew J Leventhal, Elizabeth A Morgan, et al.
Blood Advances
|
March 22, 2023
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions
Amy E DeZern, Johannes B Goll, R Coleman Lindsley, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
Early persistence of recipient stem-cells and T-cell dysregulation are associated with relapse after transplant in AML/MDS
Nurefsan E Sariipek, Ksenia R Safina, Wesley S Lu, et al.
Blood Advances
|
October 6, 2021
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Science (New York, N.Y.)
|
August 10, 2019
A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignancies
Steffen Boettcher, Peter G Miller, Rohan Sharma, et al.
Blood
|
May 21, 2021
The clinical and functional effects of TERT variants in myelodysplastic syndrome
Christopher R Reilly, Mikko Myllymäki, Robert Redd, et al.
Page
of 90
Search research articles
Search
Showing results (831-840 of 898) with videos related to
Sort By:
Page
of 90
American Journal of Surgery
|
August 8, 2022
Patient characteristics and diagnostic tests associated with syncopal falls: A Southwestern surgical congress multicenter study
Janet S Lee, Abid D Khan, Christopher M Quinn, et al.
Blood
|
March 14, 2022
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML
H Moses Murdock, Haesook T Kim, Nathan Denlinger, et al.
Blood Advances
|
June 28, 2024
Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML
Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, et al.
Blood
|
August 18, 2023
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy
Peter G Miller, Adam S Sperling, Christina Mayerhofer, et al.
Blood Advances
|
July 21, 2019
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation
Max Jan, Matthew J Leventhal, Elizabeth A Morgan, et al.
Blood Advances
|
March 22, 2023
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions
Amy E DeZern, Johannes B Goll, R Coleman Lindsley, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
Early persistence of recipient stem-cells and T-cell dysregulation are associated with relapse after transplant in AML/MDS
Nurefsan E Sariipek, Ksenia R Safina, Wesley S Lu, et al.
Blood Advances
|
October 6, 2021
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Science (New York, N.Y.)
|
August 10, 2019
A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignancies
Steffen Boettcher, Peter G Miller, Rohan Sharma, et al.
Blood
|
May 21, 2021
The clinical and functional effects of TERT variants in myelodysplastic syndrome
Christopher R Reilly, Mikko Myllymäki, Robert Redd, et al.
Page
of 90